
11 - 50 employees
Founded 2006
đ„ Healthcare
đ§Ź Biotechnology
đŹ Science
Healthcare âą Biotechnology âą Science
Xeltis is a medical technology company developing bioabsorbable vascular implants and valves that are gradually replaced by patientsâ own living tissue using its proprietary Endogenous Tissue Restoration (ETR) platform. Based on Nobel-winning polymer science, Xeltis designs implants aimed at reducing thrombosis, stenosis, calcification and infection, with key applications in hemodialysis vascular access, coronary artery bypass grafts, pulmonary valves and other vascular indications. The company is internationally active with roots in the Netherlands and focuses on transforming standard care for patients requiring vascular surgery.
Selected: đ Date Added.
đ September 29
Sales Manager launching Xeltisâs regenerative vascular implant aXess across Germany. Building hospital, clinician, and dialysis-center adoption for a new vascular-treatment category.
đŁïžđ©đȘ German Required